Agenus, Inc. (AGEN)
3.24
-0.14
(-4.14%)
USD |
NASDAQ |
Jan 23, 16:00
3.23
-0.01
(-0.31%)
Pre-Market: 20:00
Agenus Research and Development Expense (TTM): 105.60M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 55.38M |
| Cardiff Oncology, Inc. | 39.97M |
| Armata Pharmaceuticals, Inc. | 26.10M |
| Bionano Genomics, Inc. | 11.62M |
| Twist Bioscience Corp. | 80.28M |